Archer DL, Glinsmann WH (1985) Intestinal infection and malnutrition initiate AIDS. Nutrition Research 5: 19.
Becker EW, Jakover B, Luft D, Schmuelling RM (1986) Clinical and biochemical evaluations of the alga Spirulina with regard to its application in the treatment of obesity: a double-blind cross-over study. Nutr. Rep. Int. 33: 565–574.
Boudene C (1976) Evaluation of long term toxicity on rats with Spirulina. Ann. Nutr. Aliment. 30: 577–588.
Cannell R, Owsianka AM, Walker JM (1988) Results of a large-scale screening programme to detect antibacterial activity from freshwater algae. Br. phycol. J. 23: 41–44.
Chamorro-Cevalos G (1980) Toxicological research on the alga Spirulina. UNIDO, UF/MEX/78/048.
Ciferri O, Tiboni O (1985) The biochemistry and industrial potential of Spirulina. Ann. Rev. Microbiol. 39: 503–526.
Dainippon Ink & Chemicals (DIC) (1983) Antitumoral agents containing phycobillin. Japanese Patent #58-65216, inventors: N. Iijima, N. Fujii & H. Shimamatsu; assignees: Dainippon Ink & Chemicals & Tokyo Stress Foundation, Apr. 18, 6 pp.
Devi MA, Venkataraman LV (1983) Hypocholestemic effect of bluegreen algae Spirulina platensis in albino rats. Nutr. Rep. Int. 28: 519–530.
Flores E, Wolk CP (1986) Production, by filamentous, nitrogen-fixing cyanobacteria, of a bacteriocin and of other antibiotics that kill related strains. Arch. Microbiol. 145: 215–219.
Fukino H, Takagi Y, Yamane Y (1990) Effect of Spirulina (S. platensis) on the renal toxicity induced by inorganic mercury and cisplatin. Eisei Kagaku 36: 5.
Gustafson KR, Cardellina JH II, Fuller RW, Weislow OS, Kiser RF, Snader KM, Patterson GM, Boyd MR (1989) AIDS-antiviral sulfolipids from cyanobacteria (blue-green algae). J. Natl. Cancer Inst. 81: 1254–1258.
Hayashi O, Inaba Y, Matsunami K, Okuwaki Y, Kato T (1992) Paper presented at the 46th Annual Meeting of The Japanese Society of Nutrition and Food Science, Kurashiki, Japan.
Hoppe HA, Levring T, Tanaka Y, (1979) Marine algae in pharmaceutical science. Walter de Gruyter, Berlin, 807 pp.
Horrobin DF (1981a) The possible roles of prostaglandin E1 and of essential fatty acids in mannia, depression and alcoholism. Progr. Lipids 20: 539–541.
Horrobin DF (1981b) Loss of delta-6-desaturase activity as a key factor in aging. Med. Hypotheses 7: 1211–1220.
Horrobin DF, Huang YS (1983) Schizophrenia: the role of abnormal essential fatty acid and prostaglandin metabolism. Med. Hypotheses 10: 329–336.
Huang YS (1982) Most biological effects of zinc deficiency corrected by GLA. Atherosclerosis 41: 193–208.
Iwata K, Inayama T, Kato T (1987) Effects of Spirulina platensis on fructose-induced hyperlipidemia in rats. J. Jap. Soc. Nutr. Food Sci. 40: 463–467.
Iwata K, Inayama T, Kato T (1990) Effects of Spirulina platensis on plasma lipoprotein lipase activity in fructose-induced hyperlipidemic rats. J. Nutr. Sci. Vitaminol. 36: 165–171.
Jassby A (1988) Spirulina: a model for microalgae as human food. In Lembi C, Waaland JR (eds), Algae and Human Affairs. Cambridge University Press, 149–179.
Johnson P, Shubert LE (1986) Availability of iron to rats from Spirulina, a blue-green alga. Nutr. Res. 6: 85–94.
Kataoka N, Misaki A (1983) Glycolipids isolated from Spirulina maxima: structure and fatty acid composition. Agric. Biol. Chem. 47: 2349–2355.
Kato T, Takemoto K, Katayama H, Kuwabara Y (1984) Effects of Spirulina (Spirulina platensis) on dietary hypercholesterolemia in rats. J. Jap. Soc. Nutr. Food Sci. 37: 323–332.
Kernoff PBA (1977) Antithrombotic potential of DGLA in man. Br. Med. J. 2: 1441–1444.
Kunkel SL (1982) Suppression of chronic inflamation by evening primrose oil. Progr. Lipids 20: 885–888.
Nagao K., Takai Y, Ono M (1991) Exercises of growing mice, and the effect of the intake of Spirulina platensis upon the hapten-specific immune response. Sci. Phys. Power 40: 187–194.
Nakaya N, Honma Y, Goto Y (1988) Cholesterol lowering effect of Spirulina Nutr. Rep. Int. 37: 1329–1337.
Noda H, Amano H, Arashima K, Hashimoto S, Nishizawa K (1989a) Studies on the antitumor activity of marine algae. Nippon Suisan Gakkaishi 55: 1259–1268.
Noda H, Amano H, Arashima K, Hashimoto S, Nishizawa K (1989b) Antitumor activity of polysaccharides and lipids from marine algae. Nippon Suisan Gakkaishi 55: 1265–1271.
Patterson GM, Baldwin CL, Bolis CM, Caplan FR, Karuso H, Larsen LK, Levine IA, Moore RE, Nelson CS, Tschappat KD, Tuang GD, Furusawa E, Furusawa S, Norton TR, Raybcurne RB (1991) Antineoplastic activity of cultured blue-green algae (Cyanophyta). J. Phycol. 27: 530–536.
Peto R (1981) Can dietary beta carotene materially reduce human cancer rates? Nature 290: 201–208.
Qishen P, Coleman A, Baojiang G (1989) Radioprotective effect of extract from Spirulina platensis in mouse bone marrow cells studied by using the micronucleus test. Toxicology Lett. 48: 165–169.
Schwartz JL, Sklar G (1987) Regression of experimental hamster cancer by beta carotene and algae extracts. J; Oral Maxillorfac. Surg. 45: 510–515.
Schwartz JL, Sklar G, Reid S, Trickler D (1988) Prevention of experimental oral cancer by extracts of Spirulina-Dunaliella algae. Nutr. Cancer 11: 127–134.
Shekelle RB (1981) Dietary vitamin A and risk of cancer in the Western Electric Study. Lancet 8257: 1185–1189.
Takai Y, Hosoyamada Y, Kato T (1991) Effect of water-soluble and water insoluble fractions of Spirulina over serum lipids and glucose resistance of rats. J. Jap. Soc. Nutr Food Sci. 44: 273–277.
Tsuchihashi N, Watanabe T, Takai Y (1987) Effect of Spirulina platensis on caecum content in rats. Bull. Chiba Hygiene College, Chiba, Japa,. 5: 27–30.
Tudge C (1981) Why we could all need the evening primrose. New Scientist 506: 23.
Vadaddi KS, Horrobin DF (1979) Weight loss produced by evening primrose oil administration. IRSC Med. Sci. 7: 52.
Venkataraman LV, Becker EW (1985) Biotechnology and utilization of algae-The Indian experience. Sharada Press, Mangalore, India, 114–115.
Yamane Y, Fukino H, Icho T, Kato T, Shimamatsu H (1988) Effect of Spirulina (Spirulina platensis) on the renal toxicity induced by inorganic mercury and para-aminophenol. Summary of Abstracts: 108th Annual Conference of the Pharmaceutical Society of Japan, p. 58.